Understanding the Mechanism: How does the drug bimekizumab work?
•
3 min read
Bimekizumab is the first approved biologic to target both interleukin (IL)-17A and IL-17F, providing a powerful and comprehensive approach to treating chronic inflammatory diseases. Understanding **how the drug bimekizumab work**s is key to appreciating its therapeutic advancements.
